09/16/2026

FDA Workshop: 11th Annual Clinical Outcome Assessment in Cancer Trials Workshop

The FDA Oncology Center of Excellence will host the 11th Annual Clinical Outcome Assessment in Cancer Trials Workshop on October 15 from 1:00 PM-4:00 PM ET. This year's workshop asks a defining question: after more than a decade of progress in patient-reported outcome science, are we truly measuring what matters most to patients? The workshop features two panel sessions, with most panelists being patient advocates with personal cancer experience.  

Session 1 examines critical gaps in current outcome frameworks driven by novel therapies, longer survivorship, and the need for more frequent and real-time data collection.  

Session 2 takes a forward-looking view, exploring patient co-design, emerging technologies, and actionable milestones for sponsors and the research community. Together, the sessions advance FDA OCE's patient-focused drug development mission. 

To register for the workshop, go to https://fda.zoomgov.com/webinar/register/WN_1cqx8Xu5SXChX9eVIZ-QPg#/registration